Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
raleigh-durham blog main
5
×
raleigh-durham top stories
biotech
fda
national
national top stories
san francisco blog main
san francisco top stories
texas blog main
texas top stories
allergan
biogen
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
medical devices
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
surgery
venture capital
wisconsin blog main
wisconsin top stories
abbvie
acelity
acquisition
akouos
alex azar
alliance for aging research
What
plans
5
×
sciences
cash
company
life
science
acelity
acquisitions
administration
angry
announced
anti
antonio
benefited
bio
business
ceo
clearance
collabs
committed
covid
crunch
cuts
daniel
deal
decades
deploy
despite
didn’t
drug
end
far
fda
fear
fund
gilead
gilead’s
goal
hatteras
healing
Language
unset
Current search:
" raleigh-durham blog main "
×
plans
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC